NCT01630369View on ClinicalTrials.gov

Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

552

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

insulin human (HR1799)

Pharmaceutical form: solution for injection Route of administration: subcutaneous

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY